Incyte Genomics Inc (INCY) Financials
Key financial figures for Incyte Genomics Inc (Q1 2026).
- Revenue
- $1.3B
- Net Income
- $303M
- EPS
- $1.52
- Total Assets
- $7.3B
- Operating Cash Flow
- $369M
Full income statement, balance sheet, and cash flow for Incyte Genomics Inc on SentiSense.